How Often Is the Wegovy Injection Given — and Does Weekly Really Mean Weekly?

The myth: the dose going up means the injection going up too

A lot of people starting Wegovy assume that as their dose increases, so does how often they inject. It's an understandable read, more medicine sounds like more injections. It isn't. The weekly injection schedule is fixed from day one. What changes every four weeks or so, under your prescriber's guidance, is the amount of semaglutide in each pen: 0.25 mg to 0.5 mg, then 1.0 mg, 1.7 mg, and finally 2.4 mg. One injection per week throughout. The MHRA-approved regimen for Wegovy, detailed in the NHS semaglutide medicines page, makes no distinction between titration phases on frequency, it's the same day, every week, every dose.

That consistency matters clinically. Semaglutide has a half-life of roughly a week, which is precisely why the once-weekly schedule was designed as it was. Injecting more often doesn't increase effectiveness; it increases the risk of side effects without any corresponding benefit. Your prescriber will not move you to twice-weekly dosing. If you feel a single weekly dose isn't working as well as expected, the right conversation is about how often Wegovy injections are structured, which your prescriber can walk through at your next review, not a change in injection timing.

One practical note our prescribers hear regularly: people who feel the dose wearing off towards the end of the week are often experiencing normal variation rather than a dosing gap. The medicine stays active across the full seven days.

Which day you choose, and why keeping it consistent matters

You pick your injection day, and it stays as yours. Most people choose a day that fits their routine: a Monday when the week is fresh, or a Sunday before the working week begins. Once you've decided, sticking to that same day every week is more important than what the day actually is.

Gaps that regularly stretch beyond seven days mean semaglutide's steady-state concentration in your blood fluctuates more than intended. That can affect both appetite suppression and tolerability. If your usual day falls on a holiday or a busy weekend, it's fine to shift by a day or two (the SmPC allows a window of plus or minus two days) but treating the schedule as approximate every week defeats the pharmacological rationale. Some people find aligning it with another weekly habit (a specific gym class, a standing call) makes it easier to remember.

Missed doses: NHS guidance on semaglutide advises taking a missed dose as soon as you remember if there are five or more days until your next scheduled injection. If fewer than five days remain, skip the missed dose and carry on with your regular day. Never take two doses in one week. This is standard SmPC guidance, confirm it in the Patient Information Leaflet that comes with your pen.

The Wegovy pen's design helps here: the auto-inject mechanism means administration takes seconds once the pen is at the right temperature.

Side effects and the weekly rhythm: what changes as you titrate

The most commonly reported side effects with Wegovy (nausea, loose stools, indigestion, fatigue) tend to cluster in the days just after each injection, particularly around dose increases. This isn't a reason to extend your dosing interval; it's a reason to plan around it. Some people inject on a Friday evening so any nausea settles over a quieter weekend. That timing is yours to choose.

As your system adapts, most gastrointestinal effects ease within one to two weeks of starting a new dose level. Staying well hydrated and eating smaller portions helps the adjustment. If side effects are persistent or severe at any dose, contact your prescriber, don't reduce the injection frequency on your own initiative. Frequency changes are not the clinical lever for managing tolerance.

In January 2026 the MHRA issued updated guidance highlighting acute pancreatitis as a known but infrequent risk with GLP-1 medicines: severe, persistent abdominal pain that radiates to the back is a reason to stop the injection and seek urgent medical help. Any suspected side effects can also be reported at the MHRA's Yellow Card scheme.

Wegovy is a prescription-only medicine. Whether you're checking your eligibility for treatment or already in a titration programme, questions about adjusting schedule, switching doses, or stopping belong with a prescriber, and understanding how often Wegovy is injected is a good starting point before those conversations. That applies equally to private and NHS routes. For a broader look at where Wegovy sits among the licensed options, the weight-loss treatments overview covers the current landscape.